Table 2.
Clinical characteristics of paediatrics patients underwent surgery at SPHMMC from June 1 to October 30, 2022
| Characteristics | Category | Freq. (%) |
|---|---|---|
| ASA classification | ASA 1 | 131(87.3) |
| ASA 2 | 19(12.7) | |
| Separation from parents or caregiver | Good separation | 71(47.3) |
| Difficult separation | 79(52.7) | |
| Premedication | No | 78(52.0) |
| Yes | 72(48.0) | |
| Previous surgical procedure or anesthesia | No | 115(76.7) |
| Yes | 35(23.8) | |
| Techniques of general anesthesia | GA/Facemask | 13(8.7) |
| GA/LMA | 34(22.7) | |
| GA/ETT | 103(68.7) | |
| General anesthesia induction agent | Ketamine | 5(3.3) |
| Propofol | 58(38.7) | |
| Ketofol | 43(28.7) | |
| Thiopental | 7(4.7) | |
| Halothane + Ketamine | 8(5.3) | |
| Halothane + Propofol | 16(10.7) | |
| Halothane + Ketofol | 13(8.7) | |
| Analgesia | Opoids | 102(68.1) |
| Non-opoids | 15(10.0) | |
| Opioids + Non-Opioids | 17(11.3) | |
| Caudal + Opioids | 9(6.0) | |
| Caudal + Non-Opioids | 7(4.7) | |
| Extubating techniques | Deep extubation | 28(18.7) |
| Awake extubation | 109(72.6) | |
| Propofol administration at the end of procedure | ||
| No | 109(72.7) | |
| Yes | 41(27.3) | |
| Types of surgery | General pediatric | 57(38.0) |
| ENT, OMF surgery | 60(40.0) | |
| Ophthalmic surgery | 17(11.3) | |
| Orthopedic and plastic | 16(10.7) | |
| Arrival status to PACU | Awake | 97(64.7) |
| Asleep | 53(35.3) | |
| Anesthesia duration | hr | 23(15.3) |
| hr | 127(84.7) | |
| Duration of surgery | hr | 54(36.0) |
| 1 hr | 96(64.0) | |